INDO-GLOBAL ENT. | CONSTRONICS INFRA | INDO-GLOBAL ENT./ CONSTRONICS INFRA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -31.9 | 86.3 | - | View Chart |
P/BV | x | 1.4 | 164.8 | 0.9% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
INDO-GLOBAL ENT. CONSTRONICS INFRA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO-GLOBAL ENT. Mar-20 |
CONSTRONICS INFRA Mar-24 |
INDO-GLOBAL ENT./ CONSTRONICS INFRA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 20 | 45 | 45.0% | |
Low | Rs | 20 | 5 | 398.4% | |
Sales per share (Unadj.) | Rs | 0 | 1.1 | 0.0% | |
Earnings per share (Unadj.) | Rs | -0.7 | 1.0 | -65.8% | |
Cash flow per share (Unadj.) | Rs | -0.7 | 1.0 | -63.4% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 11.1 | 1.3 | 829.1% | |
Shares outstanding (eoy) | m | 6.37 | 7.21 | 88.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 23.5 | - | |
Avg P/E ratio | x | -31.1 | 25.4 | -122.7% | |
P/CF ratio (eoy) | x | -31.1 | 24.4 | -127.6% | |
Price / Book Value ratio | x | 1.8 | 18.8 | 9.8% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 130 | 182 | 71.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1 | 1 | 40.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 8 | 0.0% | |
Other income | Rs m | 0 | 5 | 0.0% | |
Total revenues | Rs m | 0 | 13 | 0.0% | |
Gross profit | Rs m | -1 | 3 | -45.6% | |
Depreciation | Rs m | 0 | 0 | 0.0% | |
Interest | Rs m | 1 | 0 | 690.0% | |
Profit before tax | Rs m | -2 | 8 | -28.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 2 | 1 | 367.3% | |
Profit after tax | Rs m | -4 | 7 | -58.2% | |
Gross profit margin | % | 0 | 41.4 | - | |
Effective tax rate | % | -93.4 | 7.1 | -1,308.9% | |
Net profit margin | % | 0 | 92.7 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 0 | 59 | 0.1% | |
Current liabilities | Rs m | 7 | 1 | 631.2% | |
Net working cap to sales | % | 0 | 743.0 | - | |
Current ratio | x | 0 | 53.7 | 0.0% | |
Inventory Days | Days | 0 | 272 | - | |
Debtors Days | Days | 0 | 262 | - | |
Net fixed assets | Rs m | 80 | 7 | 1,102.2% | |
Share capital | Rs m | 64 | 72 | 88.4% | |
"Free" reserves | Rs m | 7 | -62 | -11.2% | |
Net worth | Rs m | 71 | 10 | 732.5% | |
Long term debt | Rs m | 2 | 55 | 4.3% | |
Total assets | Rs m | 80 | 66 | 121.6% | |
Interest coverage | x | -2.1 | 78.1 | -2.7% | |
Debt to equity ratio | x | 0 | 5.7 | 0.6% | |
Sales to assets ratio | x | 0 | 0.1 | 0.0% | |
Return on assets | % | -4.4 | 11.0 | -39.4% | |
Return on equity | % | -5.9 | 74.2 | -8.0% | |
Return on capital | % | -2.0 | 12.1 | -16.6% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -1 | -2 | 80.6% | |
From Investments | Rs m | NA | -5 | -0.0% | |
From Financial Activity | Rs m | 1 | 53 | 2.6% | |
Net Cashflow | Rs m | 0 | 46 | 0.0% |
Indian Promoters | % | 2.8 | 10.6 | 26.5% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 97.2 | 89.4 | 108.7% | |
Shareholders | 543 | 3,707 | 14.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO-GLOBAL ENT. With: APOLLO HOSPITALS NARAYANA HRUDAYALAYA DR. LAL PATHLABS KIMS METROPOLIS HEALTHCARE
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO-GLOBAL ENT. | INNOVATION MEDICAL |
---|---|---|
1-Day | -4.76% | -4.62% |
1-Month | 6.24% | 3.63% |
1-Year | -13.28% | 805.49% |
3-Year CAGR | -7.78% | 136.23% |
5-Year CAGR | -4.74% | 95.81% |
* Compound Annual Growth Rate
Here are more details on the INDO-GLOBAL ENT. share price and the INNOVATION MEDICAL share price.
Moving on to shareholding structures...
The promoters of INDO-GLOBAL ENT. hold a 2.8% stake in the company. In case of INNOVATION MEDICAL the stake stands at 10.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO-GLOBAL ENT. and the shareholding pattern of INNOVATION MEDICAL.
Finally, a word on dividends...
In the most recent financial year, INDO-GLOBAL ENT. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
INNOVATION MEDICAL paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of INDO-GLOBAL ENT., and the dividend history of INNOVATION MEDICAL.
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.